Ilika, Galliford Try, Creo Medical, HANetf, Pantheon International - Small Cap Week in Review
Published: 08:10 07 Mar 2025 EST
Ilika PLC (AIM:IKA, OTCQX:ILIKF) has hit a major milestone, successfully prototyping its 50Ah Goliath EV battery with a 25-fold capacity increase. The company is scaling production to meet industry requirements, with a number of prototype releases expected by the end of the year.
Galliford Try Holdings PLC (LSE:GFRD) has delivered its ninth straight half-year of growth, with revenue up 13% to £920 million. CFO Kris Hampson says the company has secured all its water structure framework targets, strengthening its long-term order book.
Creo Medical Group PLC (AIM:CREO) is shifting from a development-stage company to a commercially profitable business, with strong US growth and new product launches, including the SpydrBlade product this year. A €30 million deal with Micro-Tech has also boosted cash reserves, supporting expansion in Europe, South America, and Asia.
Sprott Asset Management and HANetf have launched the Sprott Physical Uranium ETC (ISE:SPUT), giving European investors easier access to uranium investment. CEO John Ciampaglia says uranium demand is rising as nuclear energy plays a bigger role in global power security.
Pantheon International PLC (LSE:PIN) saw a 3.2% portfolio value increase, driven by strong exits and valuation gains. The company is buying back shares, adjusting its credit facility, and planning new investments to boost long-term growth.
